Jona Dunphy, NP
Adult Health · East Bridgewater, MANPI 1265832919
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 153 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 14.7% — the pattern of someone who eats at a lot of different presentations. Among adult health clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 153 payments — averaging $19.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$436
- Lilly USA, LLC$249
- Novo Nordisk$241
- Abbott$219
- Pfizer$148
- AstraZeneca$134
- plus $2K from 31 others
What the payments were for
- Food & beverage$2,972100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 22 | $436 |
| Lilly USA, LLC | 13 | $249 |
| Novo Nordisk | 13 | $241 |
| Abbott | 11 | $219 |
| Pfizer | 9 | $148 |
| AstraZeneca | 7 | $134 |
| Amgen | 4 | $116 |
| Neurocrine Biosciences, Inc. | 6 | $113 |
| Johnson & Johnson | 8 | $110 |
| Otsuka America Pharmaceutical, Inc. | 5 | $108 |
| Novartis | 6 | $107 |
| Lundbeck LLC | 5 | $102 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $81 |
| Bayer | 3 | $67 |
| GSK | 3 | $65 |
| Merck | 3 | $65 |
| Boehringer Ingelheim | 3 | $61 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $57 |
| Gilead | 3 | $54 |
| Medtronic | 2 | $45 |
| Eisai Inc. | 2 | $39 |
| Nestle Healthcare Nutrition Inc. | 2 | $38 |
| Alnylam Pharmaceuticals Inc. | 1 | $30 |
| Verona Pharma, Inc. | 1 | $26 |
| Mylan Specialty L.p. | 2 | $25 |
| Astellas Pharma US Inc | 1 | $23 |
| Sanofi Pasteur Inc. | 1 | $22 |
| ANI Pharmaceuticals, Inc. | 1 | $22 |
| Phathom Pharmaceuticals, Inc. | 1 | $22 |
| Sanofi-aventis U.S. LLC | 1 | $20 |
| Exact Sciences | 1 | $20 |
| Amneal Pharmaceuticals LLC | 1 | $19 |
| Cequr Corporation | 1 | $19 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| Esperion Therapeutics, Inc. | 1 | $17 |
| Avanir Pharmaceuticals, Inc. | 1 | $16 |
| Insmed, Inc. | 1 | $16 |
How this compares
$2,972 in reported general payments places this provider in the 90th percentile of 671 adult health providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 57 | $54,538 |
| TrulicityDulaglutide | 26 | $29,732 |
| JardianceEmpagliflozin | 11 | $18,310 |
| EliquisApixaban | 16 | $16,526 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 11 | $9,391 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 18 | $4,631 |
| XareltoRivaroxaban | 15 | $4,308 |
| Lidocaine | 29 | $3,431 |
| Lacosamide | 12 | $3,281 |
| Atorvastatin Calcium | 212 | $2,966 |
| Gabapentin | 195 | $2,664 |
| Levothyroxine Sodium | 172 | $2,495 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 87 | $1,922 |
| Rosuvastatin Calcium | 80 | $1,911 |
| Omeprazole | 130 | $1,812 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $241 | $54,53857 claims |
| Lilly USA, LLCTrulicity | $249 | $29,73226 claims |
| Boehringer IngelheimJardiance | $61 | $18,31011 claims |
| PfizerEliquis | $148 | $16,52616 claims |
| GSKTrelegy Ellipta | $65 | $9,39111 claims |
| Johnson & JohnsonXarelto | $110 | $4,30815 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $19 | $2,495172 claims |
| ANI Pharmaceuticals, Inc.Valsartan | $22 | $70725 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 671 adult health providers in Massachusetts.
Other adult health in East Bridgewater
- Krista TuckerBoston$157K
- Kathleen Dietz LovettHyannis$123K
- Caitlin ReenCharlestown$89K
- Tiffini ReedyFall River$58K
- Christine AgiusBoston$32K
- Amy PierreJamaica Plain$27K
- Josie BazemoreBoston$22K
- Jill TerrienWorcester$18K
- Beverly HarrisGroton$15K
- Kelly GoodwinFranklin$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.